Extraordinary General Meeting approved the sale of
PetroquímicaSuape and Citepe


Rio de Janeiro, March 27, 2017 - Petróleo Brasileiro S.A. – Petrobras, in
continuation to the material fact disclosed on December 28, 2016, informs that,
today, the Shareholders’ Extraordinary General Meeting approved the sale of 100%
of the shares held by Petrobras in PetroquímicaSuape and Citepe to Grupo
Petrotemex S.A. de C.V. and Dak Americas Exterior, S.L, subsidiaries of Alpek,
S.A.B. de C.V. (“Alpek”), for the amount of US$ 385 million, which will be paid
on the closing date, and it is subject to working capital, net debt, and
recoverable taxes adjustments.

This transaction is part of the 2015-2016 partnership and divestment program,
that reached US$ 13.6 billion in the biennium, and it is still subject to the
fulfillment of usual precedent conditions, among them the approval of the
operation by the Administrative Council for Economic Defense (CADE). The sale is
aligned to Petrobras Strategic Plan, which provides for business portfolio
optimization with full withdrawal from petrochemical interests.

Furthermore, at the moment, there is no restriction to continuing this
transaction, since the Regional Federal Court revoked the injunction that
suspended the operation, as disclosed on the material fact of February 22, 2017.


Petrobras also clarifies that the decision of the Brazilian Federal Accounting
Court (TCU), issued and announced on March 15, 2017, does not interfere in this
sale process, due to the fact that the purchase and sale agreement of
PetroquímicaSuape and Citepe was already signed on December 28, 2016, prior to
the publication of said decision.



__________________________________________
www.petrobras.com.br/ir
Contacts:
PETRÓLEO BRASILEIRO S.A. – PETROBRAS | Investor Relations Department I e-mail:
petroinvest@petrobras.com.br
Av. República do Chile, 65 – 10th floor, 1002 – B – 20031-912 – Rio de Janeiro,
RJ | Phone: 55 (21) 3224-1510 / 3224-9947

FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, that are subject to risks and uncertainties.
The forward-looking statements, which address the Company’s expected business
and financial performance, among other matters, contain words such as “believe,”
“expect,” “estimate,” “anticipate,” “optimistic,” “intend,” “plan,” “aim,”
“will,” “may,” “should,” “could,” “would,” “likely,” and similar expressions.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date on which they are made. There is no
assurance that the expected events, trends or results will actually occur. We
undertake no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information or future events or for any
other reason.

The Company’s actual results could differ materially from those expressed or
forecast in any forward-looking statements as a result of a variety of
assumptions and factors. These factors include, but are not limited to, the
following: (i) failure to comply with laws or regulations, including fraudulent
activity, corruption, and bribery; (ii) the outcome of ongoing corruption
investigations and any new facts or information that may arise in relation to
the “Lava Jato Operation”; (iii) the effectiveness of the Company’s risk
management policies and procedures, including operational risk; and (iv)
litigation, such as class actions or proceedings brought by governmental and
regulatory agencies.  A description of other factors can be found in the
Company’s Annual Report on Form 20-F for the year ended December 31, 2015, and
the Company’s other filings with the U.S. Securities and Exchange Commission.